Narayana Hrudayalaya Ltd Q2 FY27 results (latest), Jul–Sep 2026 →Revenue ₹2,844 Cr +73% YoYSee revenue, profit and what management said. You are viewing Q4 FY26.
NH

Narayana Hrudayalaya Ltd

Q4 FY26Healthcare Services

Narayana Hrudayalaya Q4 FY26 earnings call: Revenue & Margins

Q4 FY26 earnings call: what management said on revenue, margins and capex.

Revenue
₹2,594Cr
+75.9% YoY
+20.6% QoQ
Net profit
₹224Cr
+13.7% YoY
+76.4% QoQ
Margin
20%
−4 pp YoY
+3 pp QoQ
Price₹1,816
Market cap₹38.9K Cr
P/E45.1

The short version

Clinic business to be integrated with hospital business from FY27, reflecting better contribution measurement. Narayana Hrudayalaya is in an expansion phase, investing heavily (USD 100 million capex; INR 3,000 crores planned in India) to fuel growth, which may dilute short-term ROCE/ROE but is expected to be accretive long-term.

From Narayana Hrudayalaya Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.

Revenue & Sales Performance

  • Clinic business to be integrated with hospital business from FY27, reflecting better contribution measurement.
  • Focus on domestic patients to replace international patient volumes, with no active international marketing currently.
  • Investment in digital marketing, integrated care, clinics, insurance, and strengthening clinical teams expected to drive volume growth in Eastern region within 2-3 quarters.
  • No immediate expansion plans in North and West clusters; focus on expanding adult programs in existing Mumbai SRCC hospital.
  • Clinics serve as initial patient contact points, expected to shift patient preference from hospitals to clinics, supporting hospital expansion.
  • ARPP (Average Revenue per Patient) growth anticipated through advanced procedures and case mix optimization.

2 more points from Narayana Hrudayalaya Ltd's call on revenue

Create a free account to keep reading this call

Profitability & Margins

See what Narayana Hrudayalaya Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

  • FY26 greenfield capex was INR 109 crores, lower than the planned INR 424 crores, mainly due to election-related labor shortages and delays in permissions; FY28 commissioning timeline for Rajarhat, HSR, Raipur, Bangalore still on track.
  • Total proposed capex for projects is INR 3,000 crores, with greenfield organic capex of INR 460 crores; expected to commission INR 1,000 crores each in FY28 and FY29.
  • India capex details are in the IR deck; no additional capex planned for Cayman;
  • Clinics are expanding: currently 11 clinics in Bangalore, expanding to Calcutta in FY27, aiming to double clinic numbers cautiously balancing cash losses and property acquisition.

2 more points from Narayana Hrudayalaya Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Healthcare Services

Ranked on what management guided this quarter

Guidance-ranked
Rev 1Mar 1
Rev 1Mar 3
3
Rev 2Mar 1
4
Rev 2Mar 1
5
Rev 2Mar 1
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

See what Narayana Hrudayalaya Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

See what Narayana Hrudayalaya Ltd said on order book & pipeline — free account, 30 seconds.

Narayana Hrudayalaya Ltd — Quarterly revenue & net profit

Revenue Net profit
Jun 2025Q1 FY26
Sep 2025Q2 FY26
Dec 2025Q3 FY26
Mar 2026Q4 FY26
Jun 2026Q1 FY27
Sep 2026Q2 FY27

Narayana Hrudayalaya Ltd Q4 FY26 results — key figures

Narayana Hrudayalaya Ltd Q4 FY26 reported results vs Q4 FY25, ₹ crore
₹ CrQ4 FY26Q4 FY25YoYQ3 FY26QoQ
Revenue2,5941,475+75.9%2,151+20.6%
Operating profit (EBITDA)508358+41.9%365+39.2%
Operating margin20%24%-4 pp17%+3 pp
Profit before tax288254+13.4%149+93.3%
Net profit (PAT)224197+13.7%127+76.4%
EPS (₹)10.969.65+13.6%6.20+76.8%

Source: reported quarterly figures (Screener), ₹ crore.

Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹2.8K Cr, net profit ₹301 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

Others in Healthcare Services this season

  • Suven Life Sciences (Q4 FY26)

    The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su

  • Invicta Diagnostic (Q4 FY26)

    Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…

  • KMC Speciality (Q4 FY26)

    Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…

  • Star Imaging (Q4 FY26)

    Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Narayana Hrudayalaya Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Narayana Hrudayalaya Ltd Q4 FY26 results?

Clinic business to be integrated with hospital business from FY27, reflecting better contribution measurement. Narayana Hrudayalaya is in an expansion phase, investing heavily (USD 100 million capex; INR 3,000 crores planned in India) to fuel growth, which may dilute short-term ROCE/ROE but is expected to be accretive long-term.

What is Narayana Hrudayalaya Ltd share price analysis?

Narayana Hrudayalaya Ltd currently shows a neutral. The stock trades at a P/E of 45.1 with a market cap of ₹38,892 Cr. Investors should review the full earnings analysis for detailed insights.

Is Narayana Hrudayalaya Ltd planning capital expenditure?

FY26 greenfield capex was INR 109 crores, lower than the planned INR 424 crores, mainly due to election-related labor shortages and delays in permissions; FY28 commissioning timeline for Rajarhat, HSR, Raipur, Bangalore still on track.

Keep Narayana Hrudayalaya Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.